Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
To the editor: We read the interesting secondary analysis of the 4.9-year Treating to New Targets (TNT) study1 reporting the effects of aggressive low-density lipoprotein cholesterol lowering in women (median age 63.5 years) with stable coronary heart disease. In view of the reported data, we have serious concerns about the large excess in cancer mortality seen among the women randomised to high-dose atorvastatin (80 mg daily) therapy compared with …
Competing interests: None.